Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. 2000

K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. alektiak@mskcc.org

OBJECTIVE Adjuvant radiotherapy (RT) has been shown to improve local control in patients with soft tissue sarcoma of the extremities (STS). The specific impact of adjuvant radiation on patients with positive margins, however, has not been clearly defined. The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection. METHODS Between 8/82 and 2/97, 110 adult patients with primary high-grade STS of an extremity underwent limb sparing surgery and were found to have a histologically positive microscopic surgical margin. Ninety-one (83%) received RT and 19 (17%) had no RT. The two groups were balanced with regard to size, site, location, and tumor depth. Adjuvant RT was delivered with brachytherapy (BRT) alone in 34 patients, external beam radiotherapy (EBRT) alone in 33 patients, or BRT+EBRT in 24 patients. The BRT dose was 45 Gy when used alone and 15-20 Gy when used as a boost. The EBRT dose was 60-70 Gy when used alone and 45-50 Gy when given with BRT. The median follow-up time was 41 months (range, 3-186 months). RESULTS The overall 5 year local control rate was 71%. This rate was significantly higher in the RT group compared to the no RT group (74% vs. 56%, respectively) (p = 0.01). On univariate analysis, lower extremity site and proximal location were also found to be predictors of improved local control (p = 0.03 and 0.03, respectively). However, only proximal location and the use of RT retained their significance as predictors of improved local control on multivariate analysis (p = 0.003 and 0.01, respectively). The overall 5-year distant relapse-free survival, disease-free survival, and overall survival rates were 54%, 44%, and 53%, respectively. No statistical differences were found in these survival rates between RT and no RT groups. CONCLUSIONS Based on this study, adjuvant radiotherapy seems to improve local control in patients with high-grade STS of the extremity with positive margins. However, local recurrence still occurs in a substantial proportion of patients, mandating further need for improvement.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
January 2002, Annals of surgical oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
November 2004, Annals of oncology : official journal of the European Society for Medical Oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
June 2001, Clinical orthopaedics and related research,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
December 1999, Surgical oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
November 1982, Journal of surgical oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
February 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
January 2008, International journal of radiation oncology, biology, physics,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
September 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
March 2018, American journal of clinical oncology,
K M Alektiar, and J Velasco, and M J Zelefsky, and J M Woodruff, and J J Lewis, and M F Brennan
February 1988, American journal of clinical oncology,
Copied contents to your clipboard!